減重護理市場規模、佔有率和成長分析（按程序類型、藥物類型、最終用戶和地區）- 行業預測，2025-2032 年

2023年全球肥胖治療市場規模預計為93.9億美元，預計將從2024年的97.0億美元成長到2032年的125.8億美元，預測期內（2025-2032年）的複合年成長率為3.3%。

由於肥胖症的盛行率不斷上升以及糖尿病、心血管疾病和某些癌症等相關健康風險，全球肥胖症治療市場正在快速成長。這種快速成長主要是由於久坐的生活方式、不良的飲食習慣和遺傳因素造成的。因此，迫切需要有效的肥胖症治療方法。該市場的關鍵參與者包括提供已通過核准的藥物的製藥公司，這些藥物透過抑制食慾或增加能量消耗來幫助減肥。此外，減重手術等外科手術選擇和胃內水球等醫療設備也有助於增強體重管理效果。生活方式的改變也扮演著重要角色。這個充滿活力的產業為醫療保健相關人員之間的創新、投資和合作提供了重要機會，以有效對抗肥胖症流行。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

肥胖治療市場規模（按手術類型和複合年成長率） (2025-2032)

• 市場概況
• 膽胰分流術及十二指腸轉位術 (BPD/DS)
• 胃束帶手術調整
• 胃繞道手術手術
• 袖狀切除術
• 內視鏡手術

肥胖治療市場規模：藥物類型與複合年成長率（2025-2032）

• 市場概況
• 食慾抑制劑
• 伴隨用藥
• 吸收不良
• 飽腹藥水

肥胖治療市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 診所
• 美容機構
• 其他

肥胖治療市場規模（按地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Novo Nordisk（Denmark）
• Eli Lilly and Company（United States）
• Roche（Switzerland）
• GlaxoSmithKline（GSK）（United Kingdom）
• AstraZeneca（United Kingdom）
• Johnson & Johnson（United States）
• Sanofi（France）
• Pfizer（United States）
• Amgen（United States）
• Boehringer Ingelheim（Germany）
• Medtronic（Ireland）
• Altimmune（United States）
• Viking Therapeutics（United States）
• Structure Therapeutics（United States）
• NovoCure（United States）
• Arena Pharmaceuticals（United States）
• Rhythm Pharmaceuticals（United States）
• Zafgen（United States）
• Vivus（United States）

結論和建議

Global Obesity Treatment Market size was valued at USD 9.39 billion in 2023 and is poised to grow from USD 9.7 billion in 2024 to USD 12.58 billion by 2032, growing at a CAGR of 3.3% during the forecast period (2025-2032).

The global obesity treatment market is experiencing rapid growth due to the escalating prevalence of obesity and its associated health risks including diabetes, cardiovascular diseases, and specific cancers. This surge is largely attributed to sedentary lifestyles, poor dietary choices, and genetic factors. As a result, there's an urgent demand for effective obesity interventions. Key players in this market include pharmaceutical companies offering approved medications that aid weight loss by suppressing appetite or enhancing energy expenditure. Additionally, surgical options like bariatric surgery and medical devices such as gastric balloons enhance weight management efforts. Lifestyle modifications play a crucial role as well. This dynamic sector presents substantial opportunities for innovation, investment, and collaboration among healthcare stakeholders to combat the obesity epidemic effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Obesity Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Obesity Treatment Market Segmental Analysis

Global Obesity Treatment Market is segmented by Surgery Type, Drug Type, End User and region. Based on Surgery Type, the market is segmented into Biliopancreatic diversion with Duodenal Switch (BPD/DS), Adjusting Gastric Banding, Roux-en-Y Gastric Bypass, Sleeve gastrectomy and Endoscopic Procedures. Based on Drug Type, the market is segmented into Appetite suppressants, Combination drugs, Malabsorption and Satiety drugs. Based on End User, the market is segmented into Hospital, Clinics, Beauty institutions and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Obesity Treatment Market

The global obesity treatment market is significantly propelled by the alarming increase in obesity rates worldwide. Contributing factors include sedentary lifestyles, poor dietary choices, and genetic tendencies, all of which have intensified this public health crisis. As the prevalence of obesity continues to rise, so does the urgency for effective treatment options aimed at mitigating the associated health risks. This pressing need is fostering a greater demand for innovative obesity treatment solutions, pushing the market forward and creating opportunities for new therapies and programs that can effectively combat this escalating issue.

Restraints in the Global Obesity Treatment Market

The Global Obesity Treatment market faces significant restraints due to the limited or sometimes nonexistent insurance coverage for obesity-related therapies. Many insurance providers impose strict eligibility criteria for coverage, such as requiring individuals to meet specific Body Mass Index (BMI) thresholds or to prove unsuccessful attempts at previous weight loss methods. This restrictive insurance landscape can severely limit access to essential treatments, leading to challenges in managing obesity effectively. As a result, individuals may struggle to obtain the care they need, undermining efforts to combat obesity on a broader scale and potentially reducing the overall success rates of treatment programs.

Market Trends of the Global Obesity Treatment Market

The Global Obesity Treatment market is witnessing a significant trend towards personalized medicine, driven by the recognition of obesity as a multifaceted condition influenced by genetic and metabolic variations. Recent advancements in genomic research and biomarker identification are facilitating the creation of tailored therapies that align with individual patient profiles. This shift not only enhances the efficacy of treatments but also encourages patient adherence, setting the stage for a new wave of precision medications and targeted interventions. As healthcare providers increasingly embrace this customized approach, the market is poised for growth, underscoring the importance of understanding individual differences in obesity management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Obesity Treatment Market Size by Surgery Type & CAGR (2025-2032)

• Market Overview
• Biliopancreatic diversion with Duodenal Switch (BPD/DS)
• Adjusting Gastric Banding
• Roux-en-Y Gastric Bypass
• Sleeve gastrectomy
• Endoscopic Procedures

Global Obesity Treatment Market Size by Drug Type & CAGR (2025-2032)

• Market Overview
• Appetite suppressants
• Combination drugs
• Malabsorption
• Satiety drugs

Global Obesity Treatment Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital
• Clinics
• Beauty institutions
• Others

Global Obesity Treatment Market Size & CAGR (2025-2032)

• North America (Surgery Type, Drug Type, End User)
  • US
  • Canada
• Europe (Surgery Type, Drug Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Surgery Type, Drug Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Surgery Type, Drug Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Surgery Type, Drug Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (GSK) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altimmune (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viking Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Structure Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NovoCure (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arena Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rhythm Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zafgen (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivus (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations